Abstract:
Cognitive impairment in patients with type 2 diabetes mellitus is one of the actual problems not only of neurology, but also of geriatric medicine. Cognitive impairment is one of the main factors influencing the quality and life expectancy of patients, achieving full effectiveness of the process of treating the underlying disease - diabetes, as well as the formation of an adequate worldview of the patient to his illness.The study involved 126 patients undergoing inpatient treatment. The MMSE test and blood glycemic indicators were studied. In patients with type 2 diabetes mellitus and stage 3 chronic cerebral ischemia, increasingly severe cognitive impairment is observed. Cognitive impairment is directly proportional to blood glycemic indicators. These indicators show that the role of persistent hyperglycemia in the development of cognitive impairment is significant and has a negative impact on cognitive performance.
